The global Companion Diagnostics market has been anticipated to witness a crucial demand over the projected period. The global Companion Diagnostics market valued at USD 2.91 Billion in 2017 and is predicted to extend up to USD 8.91 Billion by the end of 2023, with growing CAGR of 20.50% from 2018 to 2023.
The global Companion Diagnostics report is an initiative to determine the market tendency towards the products as well as the business prominence in the industry. The report has defined the market scenario in a systematic way, focusing on the industrial development, dominant players involved in the current Companion Diagnostics market, chapter wise specification, industrial approaches, that will definitely assist our readers to aim towards the market perspective and market stability with cost-effectiveness and revenue structure.
rising cancer incidence across the globe, The growth of market is majorly driven by the factors such as improvements in regulatory guidelines, and increasing collaborations and partnerships for companion diagnostics test development. and growing need for targeted therapiesScope of the Companion Diagnostics report:
The report deliberates the Companion Diagnostics developmental strategies, manufacturing procedures and the cost structure. It also exemplifies the market segmentation, based on the types, prospective applicant, production breakdown, and the overall market view. Focusing on classification, Companion Diagnostics description, skilled analyst and a complete analysis of the market tactics involved towards the market prosperity. The information accessible in the report relates to the past and existing market opportunities and challenges confronted by the Companion Diagnostics industry.
The report represents an overall information of the global Companion Diagnostics market which includes market definition, product specification, categorizations and various other classification that are considered in analyzing the marketing strategies. Easy accessibility towards the Companion Diagnostics market share, volume, and growth rate. The report enables the market players to comprehend the costing procedure of the production, with proper analyzes of the raw materials, Companion Diagnostics demand and supply analysis of their upstream and downstream strategies. In addition to this, the report also focuses on the research and development activities, Companion Diagnostics company information, various production plants their market dimensions and so on. Forecasting the Companion Diagnostics market size and consumption rate from 2018 to 2023 for various regions, by its type and end users.
This report explains the Companion Diagnostics market based on type, key players, geological regions and end users:
Global Companion Diagnostics Market by Key Players:
F. Hoffmann-La Roche AG Agilent Technologies Inc. Qiagen N.V. Thermo Fisher Scientific Inc. Abbott Laboratories Inc. Biomrieux SA Danaher Corporation Illumina Inc. Myriad Genetics Inc. Arup Laboratories Inc. Sysmex Corporation Hologic Inc. Novartis AG Almac Group Abnova Corporation
Companion Diagnostics Market by Type:
Polymerase Chain Reaction (PCR) Immunohistochemistry (IHC) In Situ Hybridization (ISH)ďľ Next-generation Sequencing Technologies
Companion Diagnostics Market by Application:
Pharmaceutical & Biopharmaceutical Companies Reference Lab End User
Companion Diagnostics market by geographical regions/ counties analysis:
Companion Diagnostics market extends all over the world, to bifurcate few of the regions the report includes North America (USA, Canada, Mexico), Europe (France, Germany, Italy, UK, Russia), Asia Pacific (India, China, Japan, Korea) and Companion Diagnostics in the Middle East and Africa (UAE, Egypt, Saudi Arabia, Nigeria, South Africa) Rest of the World. However, technological advancement in North America is boasting the market growth, whereas Europe has been constantly enhancing the development contributing towards the growth of the Companion Diagnostics market owing to use of Companion Diagnostics in various sectors. The market in the Asia Pacific reflects a huge rise in the Companion Diagnostics market especially in India and China owing to increasing job opportunities.
Global Companion Diagnostics market report involves business scenario, which includes income, cost, and sales by type and end user, along with market stake. The report also describes the Companion Diagnostics market region wise and key players their sales and revenue over the forecast period 2018-2023.
Companion Diagnostics report includes 15 topics highlighting the key points considered in the global Companion Diagnostics market:
Topic 1 Elaborates the Companion Diagnostics definition, explains the scope of the product, summarize market stats, opportunities, drivers, and restraint.
Topic 2 In-depth analysis of the market competitors, along with their profitability, sales, income and market stake of Companion Diagnostics market.
Topic 3 emphasis on the targeted market competitors of Companion Diagnostics market to understand the market scenario.
Topic 4 Provides Companion Diagnostics information for each of regions along with their revenue, sales, and a market stake in the market from 2012 to 2017.
Topic 5,6,7,8 and 9 scrutinizes the major countries in the region in terms of income, sales, and market stake of Companion Diagnostics market.
Topic 10 and 11 The report execute the Companion Diagnostics market by its type and end users, specifying the distribution channel, growth value, and market share.
Topic 12 covers Companion Diagnostics market forecast by type, end users and by region along with sales and revenue from 2018 to 2023.
Topic 13, 14 and 15 report elucidates the Companion Diagnostics market dealers, distributors, export and import, demand and supply, sales channel, conclusion, various research findings, data source, and appendix.
Chapter 1 Industry Overview 1.1 Definition 1.2 Brief Introduction of Major Classifications 1.2.1 Polymerase Chain Reaction (PCR) 1.2.2 Immunohistochemistry (IHC) 1.2.3 In Situ Hybridization (ISH)? 1.2.4Next-generation Sequencing 1.2.5Other Technologies 1.3 Brief Introduction of Major Applications 1.3.1 Pharmaceutical &
Chapter 1 Industry Overview 1.1 Definition 1.2 Brief Introduction of Major Classifications 1.2.1 Polymerase Chain Reaction (PCR) 1.2.2 Immunohistochemistry (IHC) 1.2.3 In Situ Hybridization (ISH)? 1.2.4Next-generation Sequencing 1.2.5Other Technologies 1.3 Brief Introduction of Major Applications 1.3.1 Pharmaceutical & Biopharmaceutical Companies 1.3.2 Reference Lab 1.3.3 Other End User 1.3.4 1.3.5 1.4 Brief Introduction of Major Regions 1.4.1 United States 1.4.2 Europe 1.4.3 China 1.4.4 Japan 1.4.5 India Chapter 2 Production Market Analysis 2.1 Global Production Market Analysis 2.1.1 2012-2017 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis 2.1.2 2012-2017 Major Manufacturers Performance and Market Share 2.2 Regional Production Market Analysis 2.2.1 2012-2017 Regional Market Performance and Market Share 2.2.2 United States Market 2.2.3 Europe Market 2.2.4 China Market 2.2.5 Japan Market 2.2.6 India Market 2.2.7 Market Chapter 3 Sales Market Analysis 3.1 Global Sales Market Analysis 3.1.1 2012-2017 Global Sales Volume, Sales Price and Sales Revenue Analysis 3.1.2 2012-2017 Major Manufacturers Performance and Market Share 3.2 Regional Sales Market Analysis 3.2.1 2012-2017 Regional Market Performance and Market Share 3.2.2 United States Market 3.2.3 Europe Market 3.2.4 China Market 3.2.5 Japan Market 3.2.6 India Market 3.2.7 Market Chapter 4 Consumption Market Analysis 4.1 Global Consumption Market Analysis 4.1.1 2012-2017 Global Consumption Volume Analysis 4.2 Regional Consumption Market Analysis 4.2.1 2012-2017 Regional Market Performance and Market Share 4.2.2 United States Market 4.2.3 Europe Market 4.2.4 China Market 4.2.5 Japan Market 4.2.6 India Market 4.2.7 Market Chapter 5 Production, Sales and Consumption Market Comparison Analysis 5.1 Global Production, Sales and Consumption Market Comparison Analysis 5.2 Regional Production, Sales Volume and Consumption Volume Market Comparison Analysis 5.2.1 United States 5.2.2 Europe 5.2.3 China 5.2.4 Japan 5.2.5 India 5.2.6 Chapter 6 Major Manufacturers Production and Sales Market Comparison Analysis 6.1 Global Major Manufacturers Production and Sales Market Comparison Analysis 6.1.1 2012-2017 Global Major Manufacturers Production and Sales Market Comparison 6.2 Regional Major Manufacturers Production and Sales Market Comparison Analysis 6.2.1 United States 6.2.2 Europe 6.2.3 China 6.2.4 Japan 6.2.5 India 6.2.6 Chapter 7 Major Classification Analysis 7.1 2012-2017 Major Classification Market Share 7.2 Polymerase Chain Reaction (PCR) 7.3 Immunohistochemistry (IHC) 7.4 In Situ Hybridization (ISH)? 7.5Next-generation Sequencing 7.6Other Technologies Chapter 8 Major Application Analysis 8.1 2012-2017 Major Application Market Share 8.2 Pharmaceutical & Biopharmaceutical Companies 8.2.1 2012-2017 Consumption Analysis 8.2.2 Major Down Stream Customers Analysis 8.3 Reference Lab 8.3.1 2012-2017 Consumption Analysis 8.3.2 Major Down Stream Customers Analysis 8.4 Other End User 8.4.1 2012-2017 Consumption Analysis 8.4.2 Major Down Stream Customers Analysis 8.5 8.5.1 2012-2017 Consumption Analysis 8.5.2 Major Down Stream Customers Analysis 8.6Global 8.6.1 2012-2017 Consumption Analysis 8.6.2 Major Down Stream Customers Analysis Chapter 9 Industry Chain Analysis 9.1 Up Stream Industries Analysis 9.1.1 Raw Material and Suppliers 9.1.2 Equipment and Suppliers 9.2 Manufacturing Analysis 9.2.1 Manufacturing Process 9.2.2 Manufacturing Cost Structure 9.2.3 Manufacturing Plants Distribution Analysis 9.3 Industry Chain Structure Analysis Chapter 10 Global and Regional Market Forecast 10.1 Production Market Forecast 10.1.1 Global Market Forecast 10.1.2 Major Region Forecast 10.2 Sales Market Forecast 10.2.1 Global Market Forecast 10.2.2 Major Classification Forecast 10.3 Consumption Market Forecast 10.3.1 Global Market Forecast 10.3.2 Major Region Forecast 10.3.3 Major Application Forecast Chapter 11 Major Manufacturers Analysis 11.1 F. Hoffmann-La Roche AG 11.1.1 Company Introduction 11.1.2 Product Specification and Major Types Analysis 11.1.3 2012-2017 Production Market Performance 11.1.4 2012-2017 Sales Market Performance 11.1.5 Contact Information 11.2 Agilent Technologies, Inc. 11.2.1 Company Introduction 11.2.2 Product Specification and Major Types Analysis 11.2.3 2012-2017 Production Market Performance 11.2.4 2012-2017 Sales Market Performance 11.2.5 Contact Information 11.3 Qiagen N.V. 11.3.1 Company Introduction 11.3.2 Product Specification and Major Types Analysis 11.3.3 2012-2017 Production Market Performance 11.3.4 2012-2017 Sales Market Performance 11.3.5 Contact Information 11.4 Thermo Fisher Scientific Inc. 11.4.1 Company Introduction 11.4.2 Product Specification and Major Types Analysis 11.4.3 2012-2017 Production Market Performance 11.4.4 2012-2017 Sales Market Performance 11.4.5 Contact Information 11.5 Abbott Laboratories, Inc. 11.5.1 Company Introduction 11.5.2 Product Specification and Major Types Analysis 11.5.3 2012-2017 Production Market Performance 11.5.4 2012-2017 Sales Market Performance 11.5.5 Contact Information 11.6 Biom?rieux SA 11.6.1 Company Introduction 11.6.2 Product Specification and Major Types Analysis 11.6.3 2012-2017 Production Market Performance 11.6.4 2012-2017 Sales Market Performance 11.6.5 Contact Information 11.7 Danaher Corporation 11.7.1 Company Introduction 11.7.2 Product Specification and Major Types Analysis 11.7.3 2012-2017 Production Market Performance 11.7.4 2012-2017 Sales Market Performance 11.7.5 Contact Information 11.8 Illumina, Inc. 11.8.1 Company Introduction 11.8.2 Product Specification and Major Types Analysis 11.8.3 2012-2017 Production Market Performance 11.8.4 2012-2017 Sales Market Performance 11.8.5 Contact Information 11.9 Myriad Genetics, Inc. 11.9.1 Company Introduction 11.9.2 Product Specification and Major Types Analysis 11.9.3 2012-2017 Production Market Performance 11.9.4 2012-2017 Sales Market Performance 11.9.5 Contact Information 11.10 Arup Laboratories Inc. 11.10.1 Company Introduction 11.10.2 Product Specification and Major Types Analysis 11.10.3 2012-2017 Production Market Performance 11.10.4 2012-2017 Sales Market Performance 11.10.5 Contact Information 11.11 Sysmex Corporation 11.11.1 Company Introduction 11.11.2 Product Specification and Major Types Analysis 11.11.3 2012-2017 Production Market Performance 11.11.4 2012-2017 Sales Market Performance 11.11.5 Contact Information 11.12 Hologic Inc. 11.12.1 Company Introduction 11.12.2 Product Specification and Major Types Analysis 11.12.3 2012-2017 Production Market Performance 11.12.4 2012-2017 Sales Market Performance 11.12.5 Contact Information 11.13 Novartis AG 11.13.1 Company Introduction 11.13.2 Product Specification and Major Types Analysis 11.13.3 2012-2017 Production Market Performance 11.13.4 2012-2017 Sales Market Performance 11.13.5 Contact Information 11.14 Almac Group 11.14.1 Company Introduction 11.14.2 Product Specification and Major Types Analysis 11.14.3 2012-2017 Production Market Performance 11.14.4 2012-2017 Sales Market Performance 11.14.5 Contact Information 11.15 Abnova Corporation 11.15.1 Company Introduction 11.15.2 Product Specification and Major Types Analysis 11.15.3 2012-2017 Production Market Performance 11.15.4 2012-2017 Sales Market Performance 11.15.5 Contact Information 11.16 11.16.1 Company Introduction 11.16.2 Product Specification and Major Types Analysis 11.16.3 2012-2017 Production Market Performance 11.16.4 2012-2017 Sales Market Performance 11.16.5 Contact Information 11.17 11.17.1 Company Introduction 11.17.2 Product Specification and Major Types Analysis 11.17.3 2012-2017 Production Market Performance 11.17.4 2012-2017 Sales Market Performance 11.17.5 Contact Information 11.18 11.18.1 Company Introduction 11.18.2 Product Specification and Major Types Analysis 11.18.3 2012-2017 Production Market Performance 11.18.4 2012-2017 Sales Market Performance 11.18.5 Contact Information 11.19 11.19.1 Company Introduction 11.19.2 Product Specification and Major Types Analysis 11.19.3 2012-2017 Production Market Performance 11.19.4 2012-2017 Sales Market Performance 11.19.5 Contact Information 11.20 11.20.1 Company Introduction 11.20.2 Product Specification and Major Types Analysis 11.20.3 2012-2017 Production Market Performance 11.20.4 2012-2017 Sales Market Performance 11.20.5 Contact Information Chapter 12 New Project Investment Feasibility Analysis 12.1 New Project SWOT Analysis 12.2 New Project Investment Feasibility Analysis Chapter 13 Conclusions Chapter 14 Appendix Author List Disclosure Section Research Methodology Data Source Interview List Global Disclaimer